Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing® with oral amoxicillin or doxycycline in two randomized trials

Clinical Pharmacokinetics

Volumn 44, Issue 4, 2005, Pages 429-438

  Dogterom, Peter ^a,c   Van Den Heuvel, Michiel W ^a   Thomsen, Torben ^b  

^a NV Organon ^*  (Netherlands)

^b Pharm PlanNet Contract Research GmbH   (Germany)

^c Clinical Pharmacology and Kinetics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; DOXYCYCLINE; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETONOGESTREL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BACKACHE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INHIBITION; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VAGINA DISCHARGE; VAGINA RING;

ADOLESCENT; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CONTRACEPTIVE AGENTS, FEMALE; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DESOGESTREL; DOXYCYCLINE; DRUG DELIVERY SYSTEMS; ETHINYL ESTRADIOL; FEMALE; HUMANS;

EID: 18644386697     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200544040-00007     Document Type: Article

References (20)

1. Timmer CJ, Mulders TM. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet 2000; 39: 233-42
2. Dieben TO, Roumen FJ, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 2002; 100: 585-93
3. Novak A, de la Loge C, Abetz L, et al. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception 2003; 67: 187-94
4. Sparrow MJ. Pill method failures. N Z Med J 1987; 100: 102-5
5. Back DJ, Grimmer SF, Orme ML, et al. Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics. Br J Clin Pharmacol 1988; 25: 527-32
6. Shenfield GM. Oral contraceptives: are drug interactions of clinical significance? Drug Saf 1993; 9: 21-37
7. Stockley IH. Antibiotics and oral contraceptive failure: an update. Pharm J 1982; 229: 525-8
8. Zhanel GG, Siemens S, Slayter K, et al. Antibiotic and oral contraceptive drug interactions: is there a need for concern? Can J Infect Dis 1999; 10: 429-33
9. DeRossi SS, Hersh EV. Antibiotics and oral contraceptives. Dent Clin North Am 2002; 46: 653-64
10. Weaver K, Glasier A. Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill: a literature review. Contraception 1999; 59: 71-8
11. Dickinson BD, Altman RD, Nielsen NH, et al. Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol 2001; 98: 853-60
12. Archer JS, Archer DF. Oral contraceptive efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol 2002; 46: 917-23
13. In Vivo Metabolic Drug-Drug Interaction Working Group, US Department of Health and Human Services, Food and Drug Administration. In vivo drug metabolism/drug interaction studies: study design, data analysis, and recommendations for dosing and labelling, 1999 [online]. Available from URL: http://www.fda.gov/cder/guidance/2635fnl.htm#P116_5854 [Accessed 2005 Feb 2]
14. Roumen FJ, Apter D, Mulders TM, et al. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod 2001; 16: 469-75
15. Electronic Medicines Compendium. Summary of product characteristics: amoxil capsules [online]. Available from URL: http://www.medicines.org.uk [Accessed 2005 Feb 2]
16. Physician's Desk Reference. 56th ed. Montvale (NJ): Medical Economics, 2002: 1855-6
17. Orme ML, Back DJ. Factors affecting the enterohepatic circulation of oral contraceptive steroids. Am J Obstet Gynecol 1990; 163: 2146-52
18. Emery MG. Oestrogens and progestins. In: Levy RH, editor. Metabolic drug interactions. Philadelphia (PA): Lippincott Williams & Wilkins, 2000; 511-28
19. Back DJ, Breckenridge AM, Crawford FE, et al. Reduction of the enterohepatic circulation of norethisterone by antibiotics in the rat: correlation with changes in the gut flora. J Steroid Biochem 1980; 13: 95-100
20. Abrams LS, Skee D, Natarajan J, et al. Pharmacokinetic overview of Ortho Evra/Evra. Fertil Steril 2002; 77 Suppl. 2: S3-12